Promising HER2+/HR– breast cancer survival with de-escalated therapyJune 15, 2021Breast CancerOncology
Surgical outcomes favor addition of nivolumab to neoadjuvant chemo in resectable lung cancersJune 10, 2021Lung CancerOncology
Choosing the right R-CHOP dosage for elderly patients with DLBCLJune 8, 2021Lymphoma & Plasma Cell DisordersOncology
Genomic signature predicts safety of omitting RT in early breast cancerJune 7, 2021Breast CancerOncology
Pregnancy effect on chemotherapy does not affect maternal breast cancer outcomesJune 7, 2021Breast CancerOncology
NSCLC: Immune-related AEs during checkpoint inhibitor therapy may predict outcomesJune 6, 2021Lung CancerOncology
